MEAF6/PHF1 is a recurrent gene fusion in endometrial stromal sarcoma

Cancer Letters

Volumn 347, Issue 1, 2014, Pages 75-78

  Micci, Francesca ^a,b   Gorunova, Ludmila ^a,b   Gatius, Sonia ^c   Matias Guiu, Xavier ^c   Davidson, Ben ^a,d   Heim, Sverre ^a,b,d   Panagopoulos, Ioannis ^a,b  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c HOSPITAL UNIVERSITARI ARNAU DE VILANOVA   (Spain)

^d UNIVERSITY OF OSLO   (Norway)

Author keywords

Endometrial stromal sarcoma; Fusion gene; MEAF6 PHF1; Reverse transcriptase PCR; RNA sequencing

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CARCINOGENESIS; CASE REPORT; CONTROLLED STUDY; ENDOMETRIUM SARCOMA; EXON; FEMALE; GENE; GENE FUSION; GENE IDENTIFICATION; GENETIC ASSOCIATION; HUMAN; HUMAN TISSUE; MEAF6 GENE; MIDDLE AGED; NUCLEOTIDE SEQUENCE; PHF1 GENE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS;

ENDOMETRIAL STROMAL SARCOMA; FUSION GENE; MEAF6/PHF1; REVERSE TRANSCRIPTASE-PCR; RNA SEQUENCING;

AGED; BASE SEQUENCE; DNA PRIMERS; DNA-BINDING PROTEINS; ENDOMETRIAL NEOPLASMS; FEMALE; GENE FUSION; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; MIDDLE AGED; POLYMERASE CHAIN REACTION; SARCOMA; TRANSCRIPTION FACTORS; TRANSCRIPTOME;

EID: 84897035843     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2014.01.030     Document Type: Article

References (36)

1. Hendrickson M.R., Tavassoli F.A., Kempson R.L., McCluggage W.G., Haller U., Kubik-Huch R.A. Mesenchymal tumors and related lesions. World Health Organization Classification of Tumours: Pathology and Genetics of Tumors of the Breast and Female Genital Organs 2003, IARC Press, Lyon. F.A. Tavassoli, P. Devilee (Eds.).
2. Evans H.L. Endometrial stromal sarcoma and poorly differentiated endometrial sarcoma. Cancer 1982, 50:2170-2182.
3. Amant F., Vergote I., Moerman P. The classification of a uterine sarcoma as 'high-grade endometrial stromal sarcoma' should be abandoned. Gynecol. Oncol. 2004, 95:412-413.
4. Koontz J.I., Soreng A.L., Nucci M., Kuo F.C., Pauwels P., van Den B.H., Dal C.P., Fletcher J.A., Sklar J. Frequent fusion of the JAZF1 and JJAZ1 genes in endometrial stromal tumors. Proc. Natl. Acad. Sci. USA 2001, 98:6348-6353.
5. Micci F., Walter C.U., Teixeira M.R., Panagopoulos I., Bjerkehagen B., Saeter G., Heim S. Cytogenetic and molecular genetic analyses of endometrial stromal sarcoma: nonrandom involvement of chromosome arms 6p and 7p and confirmation of JAZF1/JJAZ1 gene fusion in t(7;17). Cancer Genet. Cytogenet. 2003, 144:119-124.
6. Micci F., Panagopoulos I., Bjerkehagen B., Heim S. Consistent rearrangement of chromosomal band 6p21 with generation of fusion genes JAZF1/PHF1 and EPC1/PHF1 in endometrial stromal sarcoma. Cancer Res. 2006, 66:107-112.
7. Panagopoulos I., Micci F., Thorsen J., Gorunova L., Eibak A.M., Bjerkehagen B., Davidson B., Heim S. Novel fusion of MYST/Esa1-associated factor 6 and PHF1 in endometrial stromal sarcoma. PLoS One 2012, 7:e39354.
8. Panagopoulos I., Thorsen J., Gorunova L., Haugom L., Bjerkehagen B., Davidson B., Heim S., Micci F. Fusion of the ZC3H7B and BCOR genes in endometrial stromal sarcomas carrying an X;22-translocation. Genes Chromos. Cancer 2013, 52:610-618.
9. Dewaele B., Przybyl J., Quattrone A., Finalet F.J., Vanspauwen V., Geerdens E., Gianfelici V., Kalender Z., Wozniak A., Moerman P., Sciot R., Croce S., Amant F., Vandenberghe P., Cools J., Debiec-Rychter M. Identification of a novel recurrent MBTD1-CXorf67 fusion in low-grade endometrial stromal sarcoma. Int. J. Cancer 2013, 10. 10.1002/ijc.28440.
10. Lee C.H., Marino-Enriquez A., Ou W., Zhu M., Ali R.H., Chiang S., Amant F., Gilks C.B., van de Rijn M., Oliva E., Debiec-Rychter M., Dal C.P., Fletcher J.A., Nucci M.R. The clinicopathologic features of YWHAE-FAM22 endometrial stromal sarcomas: a histologically high-grade and clinically aggressive tumor. Am. J. Surg. Pathol. 2012, 36:641-653.
11. Lee C.H., Ou W.B., Marino-Enriquez A., Zhu M., Mayeda M., Wang Y., Guo X., Brunner A.L., Amant F., French C.A., West R.B., McAlpine J.N., Gilks C.B., Yaffe M.B., Prentice L.M., McPherson A., Jones S.J., Marra M.A., Shah S.P., van de Rijn M., Huntsman D.G., Dal C.P., Debiec-Rychter M., Nucci M.R., Fletcher J.A. 14-3-3 Fusion oncogenes in high-grade endometrial stromal sarcoma. Proc. Natl. Acad. Sci. USA 2012, 109:929-934.
12. Abeler V.M., Royne O., Thoresen S., Danielsen H.E., Nesland J.M., Kristensen G.B. Uterine sarcomas in Norway. A histopathological and prognostic survey of a total population from 1970 to 2000 including 419 patients. Histopathology 2009, 54:355-364.
13. Abeler V.M., Nenodovic M. Diagnostic immunohistochemistry in uterine sarcomas: a study of 397 cases. Int. J. Gynecol. Pathol. 2011, 30:236-243.
14. L.G. Shaffer, M.L. Slovak, L.J. Campbell (Eds.), An International System for Human Cytogenetic Nomenclature, ISCN (2009), Karger S, Basel, 2009.
15. Sambrook J., Fritsch E.F., Maniatis T. Molecular Cloning: A Laboratory Manual 1989, Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
16. Nyquist K.B., Thorsen J., Zeller B., Haaland A., Troen G., Heim S., Micci F. Identification of the TAF15-ZNF384 fusion gene in two new cases of acute ymphoblastic leukemia with a t(12;17)(p13;q12). Cancer Genet. 2011, 204:147-152.
17. Ge H., Liu K., Juan T., Fang F., Newman M., Hoeck W. FusionMap: detecting fusion genes from next-generation sequencing data at base-pair resolution. Bioinformatics 2011, 27:1922-1928.
18. Nyquist K.B., Panagopoulos I., Thorsen J., Haugom L., Gorunova L., Bjerkehagen B., Fossa A., Guriby M., Nome T., Lothe R.A., Skotheim R.I., Heim S., Micci F. Whole-transcriptome sequencing identifies novel IRF2BP2-CDX1 fusion gene brought about by translocation t(1;5)(q42;q32) in mesenchymal chondrosarcoma. PLoS One 2012, 7:e49705.
19. Micci F., Thorsen J., Panagopoulos I., Nyquist K.B., Zeller B., Tierens A., Heim S. High-throughput sequencing identifies an NFIA/CBFA2T3 fusion gene in acute erythroid leukemia with t(1;16)(p31;q24). Leukemia 2013, 27:980-982.
20. Panagopoulos I., Thorsen J., Gorunova L., Micci F., Haugom L., Davidson B., Heim S. RNA sequencing identifies fusion of the EWSR1 and YY1 genes in mesothelioma with t(14;22)(q32;q12). Genes Chromos. Cancer 2013, 52:733-740.
21. Panagopoulos I., Micci F., Thorsen J., Haugom L., Buechner J., Kerndrup G., Tierens A., Zeller B., Heim S. Fusion of ZMYND8 and RELA genes in acute erythroid leukemia. PLoS One 2013, 8:e63663.
22. F. Mitelman, B. Johansson, F. Mertens, Mitelman database of chromosome aberrations and gene fusions in cancer, 2013. http://cgap.nci.nih.gov/Chromosomes/Mitelman.
23. Fletcher J.A., Kozakewich H.P., Hoffer F.A., Lage J.M., Weidner N., Tepper R., Pinkus G.S., Morton C.C., Corson J.M. Diagnostic relevance of clonal cytogenetic aberrations in malignant soft-tissue tumors. N. Engl. J. Med. 1991, 324:436-442.
24. Chiang S., Oliva E. Cytogenetic and molecular aberrations in endometrial stromal tumors. Hum. Pathol. 2011, 42:609-617.
25. D'Angelo E., Ali R.H., Espinosa I., Lee C.H., Huntsman D.G., Gilks B., Prat J. Endometrial stromal sarcomas with sex cord differentiation are associated with PHF1 rearrangement. Am. J. Surg. Pathol. 2013, 37:514-521.
26. Eryilmaz J., Pan P., Amaya M.F., Allali-Hassani A., Dong A., Adams-Cioaba M.A., Mackenzie F., Vedadi M., Min J. Structural studies of a four-MBT repeat protein MBTD1. PLoS One 2009, 4:e7274.
27. Lanzuolo C., Orlando V. Memories from the polycomb group proteins. Annu. Rev. Genet. 2012, 46:561-589. Epub: 2012 September 17. 10.1146/annurev-genet-110711-155603.
28. Benoit Y.D., Laursen K.B., Witherspoon M.S., Lipkin S.M., Gudas L.J. Inhibition of PRC2 histone methyltransferase activity increases TRAIL-mediated apoptosis sensitivity in human colon cancer cells. J. Cell Physiol. 2013, 228:764-772.
29. Margueron R., Reinberg D. The Polycomb complex PRC2 and its mark in life. Nature 2011, 469:343-349.
30. Sauvageau M., Sauvageau G. Polycomb group proteins: multi-faceted regulators of somatic stem cells and cancer. Cell Stem Cell. 2010, 7:299-313.
31. Simon C., Chagraoui J., Krosl J., Gendron P., Wilhelm B., Lemieux S., Boucher G., Chagnon P., Drouin S., Lambert R., Rondeau C., Bilodeau A., Lavallee S., Sauvageau M., Hebert J., Sauvageau G. A key role for EZH2 and associated genes in mouse and human adult T-cell acute leukemia. Genes Dev. 2012, 26:651-656.
32. Vissers J.H., Van L.M., Citterio E. The emerging role of Polycomb repressors in the response to DNA damage. J. Cell Sci. 2012, 125:3939-3948.
33. Avvakumov N., Cote J. The MYST family of histone acetyl transferases and their intimate links to cancer. Oncogene 2007, 26:5395-5407.
34. Lee K.K., Workman J.L. Histone acetyltransferase complexes: one size doesn't fit all. Nat. Rev. Mol. Cell Biol. 2007, 8:284-295.
35. Davidson B., Abeler V.M., Hellesylt E., Holth A., Shih I., Skeie-Jensen T., Chen L., Yang Y., Wang T.L. Gene expression signatures differentiate uterine endometrial stromal sarcoma from leiomyosarcoma. Gynecol. Oncol. 2013, 128:349-355.
36. Baker P., Oliva E. Endometrial stromal tumours of the uterus: a practical approach using conventional morphology and ancillary techniques. J. Clin. Pathol. 2007, 60:235-243.